Association between HLA-G 14-bp insertion/deletion polymorphism and hepatocellular carcinoma in Korean patients with chronic hepatitis B viral infection

Hepato-Gastroenterology

Volumn 60, Issue 124, 2013, Pages 796-798

  Kim, Su Kang ^a   Chung, Joo Ho ^a   Jeon, Jung Won ^b   Park, Jae Jun ^b   Cha, Jae Myung ^b   Joo, Kwang Ro ^b   Lee, Joung Il ^b   Shin, Hyun Phil ^b  

^a Kyung Hee University   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

Author keywords

Association study; Chronic hepatitis B; Hepatocellular carcinoma; HLA G; Polymorphism.

Indexed keywords

HLA DP ANTIGEN; HLA G ANTIGEN; MANNOSE BINDING LECTIN 2; PROTEIN MDM2; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

3' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; GENE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEPATITIS B; HLA G 14 BP GENE; HUMAN; KOREA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; CARCINOMA, HEPATOCELLULAR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS B, CHRONIC; HLA-G ANTIGENS; HUMANS; INDEL MUTATION; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; REPUBLIC OF KOREA;

EID: 84879571751     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge11180     Document Type: Article

References (25)

1. Altekruse SF, McGlynn KA, Reichman ME: Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009; 27:1485-1491.
2. Thomas MB, Zhu AX: Hepatocellular carcinoma: the need for progress. J Clin Oncol 2005; 23:2892-2899. (Pubitemid 46224106)
3. Shariff MI, Cox IJ, Gomaa AI, Khan SA, Gedroyc W, Taylor-Robinson SD: Hepatocellular carcinoma: current trends in world-wide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev Gastroenterol Hepatol 2009; 3:353-367.
4. Fung J, Lai CL, Yuen MF: Hepatitis B and C virus-related carcinogenesis. Clin Microbiol Infect 2009; 15:964-970.
5. Carosella ED, HoWangYin KY, Favier B, LeMaoult J: HLA-G-dependent suppressor cells: Diverse by nature, function, and significance. Hum Immunol 2008; 69:700-707.
6. Zeng MH, Fang CY, Wang SS, et al.: A study of soluble HLA-G1 protecting porcine endothelial cells against human natural killer cell-mediated cytotoxicity. Transplant Proc 2006; 38:3312-3314. (Pubitemid 44920254)
7. Bahri R, Hirsch F, Josse A, et al.: Soluble HLA-G inhibits cell cycle progression in human alloreactive T lymphocytes. J Immunol 2006; 176:1331-1339. (Pubitemid 43134274)
8. Lila N, Rouas-Freiss N, Dausset J, Carpentier A, Carosella ED: Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci U S A 2001; 98:12150-1255.
9. Rouas-Freiss N, Moreau P, Ferrone S, Carosella ED: HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism? Cancer Res 2005; 65:10139-10144. (Pubitemid 41743699)
10. Paul P, Rouas-Freiss N, Khalil-Daher I, et al.: HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci U S A 1998; 95:4510-4515. (Pubitemid 28207943)
11. Lila N, Carpentier A, Amrein C, Khalil-Daher I, Dausset J, Carosella ED: Implication of HLA-G molecule in heart-graft acceptance. Lancet 2000; 355:2138. (Pubitemid 30364668)
12. Wiendl H, Mitsdoerffer M, Hofmeister V, et al.: The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy. Brain 2003; 126:176-185. (Pubitemid 36068568)
13. Khosrotehrani K, Le Danff C, Reynaud-Mendel B, Dubertret L, Carosella ED, Aractingi S: HLA-G expression in atopic dermatitis. J Invest Dermatol 2001; 117:750-752.
14. Aractingi S, Briand N, Le Danff C, et al.: HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells? Am J Pathol 2001; 159:71-77. (Pubitemid 33704194)
15. Lafon M, Prehaud C, Megret F, et al.: Modulation of HLA-G expression in human neural cells after neurotropic viral infections. J Virol 2005; 79:15226-15237. (Pubitemid 43032305)
16. Tripathi P, Abbas A, Naik S, Agrawal S: Role of 14-bp deletion in the HLA-G gene in the maintenance of pregnancy. Tissue Antigens 2004; 64:706-710. (Pubitemid 39628052)
17. Souto FJ, Crispim JC, Ferreira SC, et al.: Liver HLA-G expression is associated with multiple clinical and histopathological forms of chronic hepatitis B virus infection. J Viral Hepat 2011; 18:102-105.
18. Cai MY, Xu YF, Qiu SJ, et al.: Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection. Clin Cancer Res 2009; 15:4686-4693.
19. Akkiz H, Sumbul AT, Bayram S, Bekar A, Akgollu E: MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population. Cancer Epidemiol 2010; 34:448-452.
20. He Y, Ni J, Chen S, Jiang Y, Jia S, Gao Y: The vascular endothelial growth factor-2549 insertion/deletion polymorphism is not associated with susceptibility to hepatocellular carcinoma in Chinese. DNA Cell Biol 2010; 29:393-396.
21. Kamatani Y, Wattanapokayakit S, Ochi H, et al.: A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 2009; 41:591-595.
22. Thio CL, Mosbruger T, Astemborski J, et al.: Mannose binding lectin genotypes influence recovery from hepatitis B virus infection. J Virol 2005; 79:9192-9196. (Pubitemid 40934830)
23. Kim YJ, Lee HS, Yoon JH, et al.: Association of TNF-alpha promoter polymorphisms with the clearance of hepatitis B virus infection. Hum Mol Genet 2003; 12:2541-2546. (Pubitemid 37220418)
24. Larsen MH, Hylenius S, Andersen AM, Hviid TV: The 3′-untranslated region of the HLA-G gene in relation to pre-eclampsia: revisited. Tissue Antigens 2010; 75:253-261.
25. Veit TD, Cordero EA, Mucenic T, et al.: Association of the HLA-G 14 bp polymorphism with systemic lupus erythematosus. Lupus 2009; 18:424-430.